Replies to post #574361 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Mav, you concisely describe the state of play. And for that reason, I have very much lowered where my exit will be from this stock.

Almost unfathomable at this stage that the only option for capital is a boutique PE group. Mi Caramba.

Why H.I.G. Capital — who’s more in the upper tier of PE investors — isn’t in the picture is a bit surprising, since there’s a direct connection to Toucan.

Unfortunately big, credible investors or big pharma are not trusting this management to deliver despite good data! ;) So many companies with great product remain a boutique shop because of bad management and execution.

[iclight]

Big pharma doesn't know this turd exists. If it did it would take their scientists and statisticians 30 minutes to read the JAMA report and see the data sucks and is unapprovable. They, like everyone else knows that ECAs can be used if well defined with patient level in the design of the P3, not after crappy data results between the blended data and the final data show failure.